logo

$5 And Under

Share SHARE

Silicon Image Inc. (SIMG) announced Tuesday morning that it agreed to be acquired by Lattice Semiconductor (LSCC) for $7.30 per share in cash, approximately $600 million. Silicon Image gapped open sharply higher Tuesday, but moved in a narrow range throughout the session. The stock closed up by 1.39...

Silicon Image Inc. (SIMG) announced Tuesday morning that it agreed to be acquired by Lattice Semiconductor (LSCC) for $7.30 per share in cash, approximately $600 million. Silicon Image gapped open sharply higher Tuesday and is now up 1.37 at $7.27 on the highest volume of the year. The stock is now...

Heat Biologics Inc. (HTBX) announced Monday morning that positive data from its Phase 1 clinical trial of HS-410 in non-muscle invasive bladder cancer was presented at the 7th Annual Phacilitate Immunotherapy Forum. The study demonstrated substantially increased tumor infiltrating lymphocytes after treatment. Heat...

Array BioPharma Inc. (ARRY) announced Friday morning that it has reached a definitive agreement to acquire the worldwide rights to encorafenib from Novartis Pharma. Array BioPharma surged to the upside in the first half hour of trade Friday, before settling into a narrow range. The stock finished...

Array BioPharma Inc. (ARRY) announced Friday morning that it has reached a definitive agreement to acquire the worldwide rights to encorafenib from Novartis Pharma. Array BioPharma has been rising sharply since the open of trade Friday and is now up 2.15 at $7.20 on above average volume. The stock...

SuperCom Ltd. (SPCB) announced a few minutes ago that it now expects revenue growth for the full year 2015 to exceed 40% on a year-over-year basis and expects non-GAAP EPS to exceed $1.20 per share. SuperCom has been rising since the open Wednesday and is now up 1.15 at $8.90. Trading volume has begun...

ZIOPHARM Oncology Inc. (ZIOP) and Intrexon Corp. announced Wednesday morning that they has entered into a license agreement with The University of Texas M.D. Anderson Cancer Center to develop cancer treatments. ZIOPHARM Oncology has gapped open dramatically higher this morning and is now up 3.59...

Emulex Corp. (ELX) announced Tuesday morning that it now expects to report second quarter revenues of $110 million to $111 million, with non-GAAP EPS between $0.23 and $0.24. Prior expectations had been for revenues of $102 million to $108 million, with non-GAAP EPS between $0.14 and $0.18. Analysts...

E2open Inc. (EOPN) reported a third quarter non-GAAP loss of $0.15 per share after the close Thursday, compared to the loss of $0.16 per share last year. Analysts had expected a loss of $0.18 per share. The company expects to report a fourth quarter non-GAAP loss of $0.22 to $0.20 per share and between...

Agenus Inc. (AGEN) announced a global license, development and commercialization agreement with Incyte Corp. (INCY) Friday morning. Incyte will make upfront payments to Agenus totaling $25 million and will also invest $35 million in the company, through the purchase of newly issued shares of Agenus. Agenus...

EDAP TMS SA (EDAP) announced Friday morning that its Focal One HIFU device has been approved by Health Canada. EDAP gapped up Friday and rose sharply in early trade. The stock has taken out the highs of the morning in the last few minutes and is now up 1.31 at $3.63 on strong volume. EDAP has surged to a 5-month high.

Agenus Inc. (AGEN) announced a global license, development and commercialization agreement with Incyte Corp. (INCY) Friday morning. Incyte will make upfront payments to Agenus totaling $25 million and will also invest $35 million in the company, through the purchase of newly issued shares of Agenus. Agenus...

E2open Inc. (EOPN) reported a third quarter non-GAAP loss of $0.15 per share after the close Thursday, compared to the loss of $0.16 per share last year. Analysts had expected a loss of $0.18 per share. The company expects to report a fourth quarter non-GAAP loss of $0.22 to $0.20 per share and between...

Star Bulk Carriers Corp. (SBLK) announced after the bell Thursday that it plans to make an underwritten public offering of its common stock. The stock is now down 1.03 on 43K shares. Star Bulk Carriers climbed for the majority of Thursday's session and finished with a gain of 0.46 at $6.53. The stock...

BIND Therapeutics Inc. (BIND) provided an update on its Phase 2 trial of BIND-014 after the bell Wednesday. The company believes that the positive results from the trial will allow it to rapidly advance the drug to phase 3. BIND Therapeutics has gapped open sharply higher Thursday morning and is now...

Follow RTT